SCHEMBL29650322

SCHEMBL29650322

CCCCCCC[C@@H](CC)C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CETP P11597 3/20 0.51
ALDH1A1 P00352 3/20 0.50
CYP3A4 P08684 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
SIRT2 Q8IXJ6 5/20 0.47
SIRT1 Q96EB6 4/20 0.47
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
CNR2 P34972 1/20 0.47
SIRT3 Q9NTG7 3/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29650273 1.00 CETP (0.51) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL27851258 1.00 CETP (0.51) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL27729776 1.00 CETP (0.51) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL28547677 1.00 CETP (0.51) CETPALDH1A1CYP3A4TSHRMAPK1
Hydrochloric Acid SCHEMBL29160806 0.99 CETP (0.50) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL29650278 0.99 CETP (0.50) CETPALDH1A1CYP3A4TSHRMAPK1
Hydrochloric Acid SCHEMBL29160910 0.99 CETP (0.50) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL3247583 0.98 ALDH1A1 (0.51) CETPALDH1A1CYP3A4TSHRMAPK1
Hydrochloric Acid SCHEMBL4060020 0.97 ALDH1A1 (0.50) CETPALDH1A1CYP3A4TSHRMAPK1
SCHEMBL3823743 0.94 CA2 (0.53) CETPALDH1A1CYP3A4TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 CN disclosed